Bio Path logo

Bio Path Share Price Today

(NASDAQ: BPTH)

Bio Path share price is $0.63 & ₹54.68 as on 15 Feb 2025, 2.30 'hrs' IST

$0.63

Market is closed - opens 8 PM, 18 Feb 2025

View live Bio Path share price in Dollar and Rupees. Guide to invest in Bio Path stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bio Path, along with analyst recommendations, forecasts, and comprehensive financials.

Bio Path share price movements

  • Today's Low: $0.60
    Today's High: $0.65

    Day's Volatility :7.68%

  • 52 Weeks Low: $0.59
    52 Weeks High: $9.83

    52 Weeks Volatility :93.96%

Bio Path (BPTH) Returns

PeriodBio Path Holdings IncIndex (Russel 2000)
3 Months
-15.58%
0.0%
6 Months
-57.79%
0.0%
1 Year
-92.75%
0.0%
3 Years
-83.89%
-14.8%

Bio Path (BPTH) Key Statistics

in dollars & INR

Previous Close
$0.63
Open
$0.63
Today's High
$0.6499
Today's Low
$0.6
Market Capitalization
$3.7M
Today's Volume
$631.4K
52 Week High
$9.83
52 Week Low
$0.593263
Revenue TTM
$0.0
EBITDA
$-12.4M
Earnings Per Share (EPS)
$-8.38
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1159.74%

How to invest in Bio Path Stock (BPTH) from India?

It is very easy for Indian residents to invest directly in Bio Path from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bio Path stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bio Path or BPTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bio Path or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bio Path shares which would translate to 1.378 fractional shares of Bio Path as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bio Path, in just a few clicks!

Returns in Bio Path (BPTH) for Indian investors in Rupees

The Bio Path stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bio Path investment value today

Current value as on today

₹11,778

Returns

₹88,222

(-88.22%)

Returns from Bio Path Stock

₹92,784 (-92.78%)

Dollar Returns

₹4,561 (+4.56%)

Indian investors sentiment towards Bio Path (BPTH)

-83%

Period: Jan 16, 2025 to Feb 15, 2025. Change in 30 Days versus previous period

Search interest for Bio Path Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bio Path

  • Apollon Wealth Management, LLC

    0.26%

  • Geode Capital Management, LLC

    0.24%

  • Vanguard Group Inc

    0.23%

  • Virtu Financial LLC

    0.21%

  • Citadel Advisors Llc

    0.19%

  • Tower Research Capital LLC

    0.06%

Analyst Recommendation on Bio Path

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Bio Path(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Bio Path Stock (BPTH)

What analysts predicted

Upside of 1804.76%

Target:

$12.00

Current:

$0.63

Insights on Bio Path Stock (Ticker Symbol: BPTH)

  • Price Movement

    In the last 7 days, BPTH stock has moved down by -18.9%
  • BPTH vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 73.9% return, outperforming this stock by 166.7%
  • BPTH vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 67.3% return, outperforming this stock by 151.3%

Bio Path Technicals Summary

Sell

Neutral

Buy

Bio Path is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bio Path (BPTH) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bio Path Holdings Inc logo
-22.78%
-57.79%
-92.75%
-83.89%
-90.23%
Biontech Se logo
6.27%
33.25%
31.33%
-23.85%
279.93%
Regeneron Pharmaceuticals, Inc. logo
-2.83%
-43.72%
-28.86%
7.48%
69.4%
Vertex Pharmaceuticals Incorporated logo
10.08%
-5.95%
9.12%
97.19%
86.64%
Alnylam Pharmaceuticals, Inc. logo
2.93%
-6.57%
71.32%
71.02%
99.29%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bio Path Holdings Inc logo
NA
NA
0.0
-3.17
-11.6
-1.94
NA
-0.19
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.57
17.57
0.99
43.2
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.28
18.13
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
1.21
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bio Path Holdings Inc logo
Buy
$3.7M
-90.23%
NA
0.0%
Biontech Se logo
Buy
$29.4B
279.93%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.7B
69.4%
17.57
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$118.8B
86.64%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.3B
99.29%
NA
-15.86%

About Bio Path

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.
Organization
Bio Path
Employees
10
CEO
Mr. Peter H. Nielsen MBA
Industry
Health Technology

Management People of Bio Path

NameTitle
Mr. Peter H. Nielsen MBA
Co-Founder, Chairman of the Board, CEO, President, CFO & Treasurer
Mr. Douglas P. Morris
Co-Founder, Director of Investor Relations, Secretary & Director
Mr. Michael Hickey M.B.A.
VP of Clinical Operations
Mr. Anthony Price MBA
Senior Vice President of Finance, Accounting & Administration
Dr. Ana Tari Ashizawa M.B.A., MBA, Ph.D.
Senior Vice President of Research, Development & Clinical Design

Important FAQs about investing in BPTH Stock from India :

What is Bio Path share price today?

Bio Path share price today stands at $0.63, Open: $0.63 ; Previous Close: $0.63 ; High: $0.65 ; Low: $0.60 ; 52 Week High: $9.83 ; 52 Week Low: $0.59.

The stock opens at $0.63, after a previous close of $0.63. The stock reached a daily high of $0.65 and a low of $0.60, with a 52-week high of $9.83 and a 52-week low of $0.59.

Can Indians buy Bio Path shares?

Yes, Indians can invest in the Bio Path (BPTH) from India.

With INDmoney, you can buy Bio Path at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bio Path at zero transaction cost.

How can I buy Bio Path shares from India?

It is very easy to buy Bio Path from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bio Path (BPTH) be purchased?

Yes, you can buy fractional shares of Bio Path with INDmoney app.

What are the documents required to start investing in Bio Path stocks?

To start investing in Bio Path, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bio Path Stock (BPTH)?

Today’s highest price of Bio Path (BPTH) is $0.65.

Today’s lowest price of Bio Path (BPTH) is $0.60.

What is today's market capitalisation of Bio Path?

Today's market capitalisation of Bio Path BPTH is 3.7M

What is the 52 Week High and Low Range of Bio Path Stock (BPTH)?

  • 52 Week High

    $9.83

  • 52 Week Low

    $0.59

What are the historical returns of Bio Path (BPTH)?

  • 1 Month Returns

    -22.78%

  • 3 Months Returns

    -57.79%

  • 1 Year Returns

    -92.75%

  • 5 Years Returns

    -90.23%

Who is the Chief Executive Officer (CEO) of Bio Path ?

Mr. Peter H. Nielsen MBA is the current Chief Executive Officer (CEO) of Bio Path.